Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Clinics and Research in Hepatology and Gastroenterology|September 3, 2023
Acute liver failure following immune checkpoint inhibitorsThomas Renault, Lucy Meunier, Clément Monet
World Journal of Gastroenterology|August 3, 2010
Is chronic hepatitis C virus infection a risk factor for breast cancer?Dominique Larrey, Marie-Cécile Bozonnat, Ihab Kain, et al.
Alimentary Pharmacology & Therapeutics|September 24, 2024
Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAMLina Hountondji, Stéphanie Faure, Pascale Palassin, et al.
Clinics and Research in Hepatology and Gastroenterology|August 11, 2023
Combination immune checkpoint therapy carried on despite grade 4 immune-related hepatotoxicity during treatment of metastatic melanoma: Case report and review of literatureAngèle Lallement, Anouck Lamoureux, Michael Hummelsberger, et al.
Clinical Nuclear Medicine|December 14, 2019
Antiviral (Hepatitis C Virus) Drug-Drug Interaction Leading to Dramatic Underestimation of Liver Function With 99mTc-Mebrofenin Hepatobiliary ScintigraphyEmmanuel Deshayes, Cyril Fersing, Lucy Meunier, et al.
Journal of Clinical Lipidology|October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)James A Underberg, Christopher P Cannon, Dominique Larrey, et al.
The Annals of Pharmacotherapy|April 23, 2009
Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitisHélène Peyrière, Ludmilla Tatem, Camille Bories, et al.
Annals of Hepatology|June 6, 2019
Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life studyVictor de Ledinghen, Bertrand Hanslik, Joseph Moussalli, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
Use of human hepatocytes to investigate HCV infectionLydiane Pichard-Garcia, Philippe Briolotti, Dominique Larrey, et al.
Drug Safety|February 22, 2011
Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgeryPaul B Watkins, Mehul Desai, Scott D Berkowitz, et al.
Pageof 17